TCM
TTOO

Traynor Capital Management’s T2 Biosystems, Inc TTOO Stock Holding History

Traynor Capital Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11
Closed -$6K – 231
2022
Q3 		$6K Buy
11
+5
+83% +$3.29K ﹤0.01% 179
2022
Q2 		$4K Buy
6
+2
+50% +$2.96K ﹤0.01% 177
2022
Q1 		$10K Hold
4
– – ﹤0.01% 201
2021
Q4 		$10K Hold
4
– – ﹤0.01% 220
2021
Q3 		$17K Buy
4
+1
+33% +$5.03K ﹤0.01% 199
2021
Q2 		$17K Hold
3
– – ﹤0.01% 187
2021
Q1 		$26K Buy
+3
New +$31.8K ﹤0.01% 179

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ML
McAdam LLC Philadelphia, Pennsylvania $2.22B AUM 16.98% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Traynor Capital Management's TTOO Position: Q4 2022 in Review

Traynor Capital Management sold out of T2 Biosystems, Inc (TTOO) in Q4 2022, closing a stake of 11 shares — an estimated $6K sold.

Traynor Capital Management first reported a position in TTOO in Q1 2021 and held it in 7 quarters. The position peaked at $26K in Q1 2021. 20 funds tracked by Wall St. Rank hold TTOO as of Q4 2022.

  • Traynor Capital Management reported no remaining T2 Biosystems, Inc position as of Q4 2022 after selling out during the quarter.
  • Traynor Capital Management sold 11 T2 Biosystems, Inc shares in Q4 2022, an estimated $6K.
  • Traynor Capital Management first reported a position in T2 Biosystems, Inc in Q1 2021 and held it in 7 quarters.
  • Traynor Capital Management's T2 Biosystems, Inc position peaked at $26K in Q1 2021.
  • 20 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2022.

Based on Traynor Capital Management's 13F filing for Q4 2022, filed 27 Jan 2023.